Volumen | 10.649 |
|
|||||
News | - | ||||||
Tageshoch | 7,9964 | Niedrig Hoch |
|||||
Tagestief | 6,75 |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Titan Pharmaceuticals Inc | TTNP | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
7,02 | 6,75 | 7,9964 | 7,09 | 6,97 |
Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|---|---|
146 | 10.649 | US$ 7,27 | US$ 77.379 | - | 5,00 - 16,60 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
00:05:31 | 1 | US$ 6,77 | USD |
Finanzwerte TTNP
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
5,54M | 781,50k | - | 184k | -5,57M | -7,13 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Titan Pharmaceuticals
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
25.1.2024 | 22:33 | Edgar (US Regulatory) | Form 8-K - Current report |
25.1.2024 | 22:29 | GlobeNewswire Inc. | Titan Pharmaceuticals Fully Compliant With NASDAQ Listing.. |
18.1.2024 | 22:59 | Edgar (US Regulatory) | Form 8-K - Current report |
08.1.2024 | 23:13 | Edgar (US Regulatory) | Form 8-K - Current report |
28.12.2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
28.12.2023 | 22:15 | GlobeNewswire Inc. | Titan Pharmaceuticals Announces Reverse Stock Split and.. |
28.11.2023 | 22:47 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
17.11.2023 | 22:03 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
15.11.2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
26.10.2023 | 22:33 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
26.10.2023 | 22:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
26.10.2023 | 22:29 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
Forum Titan Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
TTNP Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 7,21 | 7,9964 | 6,75 | 7,11 | 1.554 | -0,12 | -1,66% |
1 Monat | 7,11 | 9,07 | 6,61 | 7,14 | 5.389 | -0,02 | -0,28% |
3 Monate | 6,09 | 9,29 | 5,49 | 7,41 | 8.749 | 1,00 | 16,42% |
6 Monate | 8,29 | 10,00 | 5,00 | 7,23 | 25.467 | -1,20 | -14,48% |
1 Jahr | 15,60 | 16,60 | 5,00 | 10,04 | 43.458 | -8,51 | -54,55% |
3 Jahre | 50,00 | 62,00 | 5,00 | 22,37 | 155.094 | -42,91 | -85,82% |
5 Jahre | 1.080,00 | 1.308,00 | 5,00 | 135,88 | 4.145.368 | -1.072,91 | -99,34% |